NovaBay Pharmaceuticals, Inc. Contracts & Agreements

Trademark Acquisition Agreement, dated January 3, 2025, by and between NovaBay Pharmaceuticals, Inc. and Phase One Health, LLC (Filed With SEC on January 10, 2025)

Transition Services Agreement, dated as of January 3, 2025, by and between NovaBay Pharmaceuticals, Inc. and Phase One Health, LLC (Filed With SEC on January 10, 2025)

Amendment No. 1 to Asset Purchase Agreement, dated as of November 5, 2024, between PRN Physician Recommended Nutriceuticals, LLC and NovaBay Pharmaceuticals, Inc (Filed With SEC on November 6, 2024)

Secured Promissory Note, dated as of November 5, 2024, between NovaBay Pharmaceuticals, Inc., as borrower, and PRN Physician Recommended Nutriceuticals, LLC, as lender (Filed With SEC on November 6, 2024)

Asset Purchase Agreement, dated September 19, 2024, by and between NovaBay Pharmaceuticals, Inc. and PRN Physician Recommended Nutriceuticals, LLC (Filed With SEC on September 20, 2024)

Plan of Complete Liquidation and Dissolution of NovaBay Pharmaceuticals, Inc (Filed With SEC on September 20, 2024)

Underwriting Agreement, dated July 26, 2024, by and between NovaBay Pharmaceuticals, Inc. and Ladenburg Thalmann & Co., Inc (Filed With SEC on July 29, 2024)

Form of Series F-1 Warrant (Filed With SEC on July 29, 2024)

Form of Series F-2 Warrant (Filed With SEC on July 29, 2024)

Form of Series F-3 Warrant (Filed With SEC on July 29, 2024)

Form of Pre-Funded Warrant (Filed With SEC on July 29, 2024)

Warrant Agency Agreement, dated July 29, 2024, by and between NovaBay Pharmaceuticals, Inc. and Equinti Trust Company, LLC (Filed With SEC on July 29, 2024)

Form of Underwriting Agreement (Filed With SEC on July 10, 2024)

Form of Series F-1 Common Stock Warrant (Filed With SEC on July 10, 2024)

Form of Series F-2 Common Stock Warrant (Filed With SEC on July 10, 2024)

Form of Pre-Funded Warrant (Filed With SEC on July 10, 2024)

Form of Warrant Agency Agreement (Filed With SEC on July 10, 2024)

Form of Series E Common Stock Warrant (Filed With SEC on June 14, 2024)

Form of Letter Agreement, dated June 14, 2024 (Filed With SEC on June 14, 2024)

2024 Non-Employee Director Compensation Plan (Filed With SEC on March 26, 2024)

Form of Series D Common Stock Warrant (Filed With SEC on March 25, 2024)

Form of Unsecured Convertible Notes (Filed With SEC on March 25, 2024)

Form of First Amendment to the Security Agreement, dated March 24, 2024 (Filed With SEC on March 25, 2024)

Form of Consent and Release, dated March 24, 2024 (Filed With SEC on March 25, 2024)

Membership Unit Purchase Agreement, dated March 12, 2024, by and among the Company, DERMAdoctor, and the Buyer (Filed With SEC on March 14, 2024)

License and Distribution Agreement by and between NovaBay and Sonoma, dated, January 5, 2024 (Filed With SEC on January 10, 2024)

Form of Series C Common Stock Warrant (Filed With SEC on December 21, 2023)

Form of Letter Agreement (Filed With SEC on December 21, 2023)

Second Amendment to Executive Employment Agreement with Justin M. Hall, effective December 31, 2023 (Filed With SEC on December 11, 2023)

Form of Original Issue Discount Secured Senior Convertible Debenture (Filed With SEC on April 27, 2023)

Form of Series B-1 Long-Term Common Stock Warrant (Filed With SEC on April 27, 2023)

Form of Series B-1 Short-Term Common Stock Warrant (Filed With SEC on April 27, 2023)

Form of Warrant Amendment Agreement (Filed With SEC on April 27, 2023)

Form of Securities Purchase Agreement (Filed With SEC on April 27, 2023)

Form of Security Agreement (Filed With SEC on April 27, 2023)

Form of Subsidiary Guarantee (Filed With SEC on April 27, 2023)

Form of Voting Commitment (Filed With SEC on April 27, 2023)

Form of Registration Rights Agreement (Filed With SEC on April 27, 2023)

Description of Securities (Filed With SEC on March 31, 2023)

2023 Non-Employee Director Compensation Plan (Filed With SEC on March 31, 2023)

Consulting Agreement between the Company and Andrew Jones, dated February 15, 2023 (Filed With SEC on March 31, 2023)

Form of Amended 2020 Common Stock Warrant (Filed With SEC on September 13, 2022)

Form of Amended 2021 Common Stock Warrant (Filed With SEC on September 13, 2022)

Form of New Common Stock Warrant for 2020 Participants (Filed With SEC on September 13, 2022)

Form of New Common Stock Warrant for 2021 Participants (Filed With SEC on September 13, 2022)

Form of Series A-1 Long-Term Common Stock Warrant (Filed With SEC on September 13, 2022)

Form of Series A-2 Short-Term Common Stock Warrant (Filed With SEC on September 13, 2022)

Form of 2020 Reprice Letter Agreement (Filed With SEC on September 13, 2022)

Form of 2021 Reprice Letter Agreement (Filed With SEC on September 13, 2022)

Form of Securities Purchase Agreement (Filed With SEC on September 13, 2022)

Form of Registration Rights Agreement (Filed With SEC on September 13, 2022)

Form of Participant Voting Commitment (Filed With SEC on September 13, 2022)

Form of Additional Voting Commitment (Filed With SEC on September 13, 2022)

Form of Leak-Out Agreement (Filed With SEC on September 13, 2022)

Description of Securities (Filed With SEC on March 29, 2022)

Director and Officer Indemnity Agreement (Filed With SEC on March 29, 2022)

2022 Non-Employee Director Compensation Plan (Filed With SEC on March 29, 2022)

First Amendment to Office Lease by and between the Company and KBSIII Towers at Emeryville, LLC, dated January 24, 2022 (Filed With SEC on January 28, 2022)

First Amendment to Executive Employment Agreement with Justin M. Hall, dated January 26, 2022 (Filed With SEC on January 28, 2022)

Executive Employment Agreement with Dr. Audrey Kunin, dated November 5, 2021 (Filed With SEC on November 12, 2021)

Executive Employment Agreement with Dr. Jeff Kunin, dated November 5, 2021 (Filed With SEC on November 12, 2021)

Side Letter with Dr. Audrey Kunin, dated November 5, 2021 (Filed With SEC on November 12, 2021)

Performance Restricted Stock Unit Award Agreement with Dr. Audrey Kunin (Filed With SEC on November 12, 2021)

Membership Unit Purchase Agreement, dated September 27, 2021, by and among the Company, DERMAdoctor, the Founders and the Sellers (Filed With SEC on September 28, 2021)

At the Market Offering Agreement, dated May 14, 2021 (Filed With SEC on May 14, 2021)

Performance Restricted Stock Unit Award Agreement with Mr. Justin Hall (Filed With SEC on May 6, 2021)

Performance Restricted Stock Unit Award Agreement with Mr. Andrew Jones (Filed With SEC on May 6, 2021)

2021 Non-Employee Director Compensation Plan (Filed With SEC on May 6, 2021)

Description of Securities (Filed With SEC on March 25, 2021)

Consulting Agreement between the Company and Eric Wu, dated November 17, 2020 (Filed With SEC on November 18, 2020)

First Amendment to Services Agreement, dated September 4, 2020 (Filed With SEC on September 10, 2020)

Indemnity Agreement (Form of Indemnity Agreement between the Company and its Directors and Officers) (Filed With SEC on August 6, 2020)

Ninth Amendment to Lease between EmeryStation Office II, LLC (Landlord) and NovaCal Pharmaceuticals, Inc. (Tenant), EmeryStation North Project (Filed With SEC on August 6, 2020)

Sublease Termination Agreement by and between the Company and Zymergen, Inc (Filed With SEC on August 6, 2020)

First Amendment to Intermediary Distribution Agreement between the Company and Chongqing Pioneer Pharma Holdings Limited, dated June 29, 2020 (Filed With SEC on August 6, 2020)

Form of New Warrant (Filed With SEC on July 21, 2020)

Form of Exercise Agreement with Holders of Domestic Warrants (Filed With SEC on July 21, 2020)

Form of Exercise Agreement with Holders of Foreign Warrants (Filed With SEC on July 21, 2020)

Form of Reprice Agreement with Ladenburg (Filed With SEC on July 21, 2020)

Form of Warrant (Filed With SEC on May 18, 2020)

Services Agreement, dated May 13, 2020 (Filed With SEC on May 18, 2020)

Securities Purchase Agreement, dated May 13, 2020 (Filed With SEC on May 18, 2020)

Second Amendment to Promissory Note, dated May 14, 2020 (Filed With SEC on May 15, 2020)

Paycheck Protection Program Promissory Note and Agreement, dated May 3, 2020, between the Company and Wells Fargo Bank, N.A (Filed With SEC on May 7, 2020)

Executive Employment Agreement with Mr. Andrew Jones, dated May 4, 2020 (Filed With SEC on May 5, 2020)

At the Market Offering Agreement, dated April 27, 2020 (Filed With SEC on April 27, 2020)

Form of Warrant (Filed With SEC on April 20, 2020)

International Distribution Agreement, dated April 16, 2020 (Filed With SEC on April 20, 2020)

Intermediary Distribution Agreement, dated April 16, 2020 (Filed With SEC on April 20, 2020)

Employment Agreement with Mr. Justin Hall, dated January 31, 2020 (Filed With SEC on February 6, 2020)

Employment Agreement with Mr. Jason Raleigh, dated January 31, 2020 (Filed With SEC on February 6, 2020)

Certificate of Designation (Filed With SEC on August 13, 2019)

Form of Preferred Stock (Filed With SEC on August 13, 2019)

Placement Agency Agreement, dated as of August 8, 2019 (Filed With SEC on August 9, 2019)

Form of Common Warrant (Filed With SEC on August 9, 2019)

Form of Preferred Warrant (Filed With SEC on August 9, 2019)

Form of RD Securities Purchase Agreement, dated as of August 8, 2019 (Filed With SEC on August 9, 2019)

PIPE Securities Purchase Agreement, dated as of August 8, 2019 (Filed With SEC on August 9, 2019)

First Amendment to Promissory Note, dated June 25, 2019 (Filed With SEC on June 26, 2019)

Form of Warrant (Filed With SEC on June 19, 2019)

Securities Purchase Agreement, dated June 17, 2019 (Filed With SEC on June 19, 2019)

Common Stock Purchase Agreement, dated March 29, 2019, by and between the Company and Triton Funds LP (Filed With SEC on April 1, 2019)

Registration Rights Agreement, dated March 29, 2019, by and between the Company and Triton Funds LP (Filed With SEC on April 1, 2019)

Letter Agreement, dated March 29, 2019, by and between the Company and Triton Funds LLC (Filed With SEC on April 1, 2019)

Consulting Agreement between the Company and China Kington, dated March 1, 2019 (Filed With SEC on March 29, 2019)

Term Sheet between the Company and the Institutional Investor, dated March 25, 2019 (Filed With SEC on March 28, 2019)

Securities Purchase Agreement between the Company and Iliad Research and Trading, L.P., dated March 26, 2019 (Filed With SEC on March 28, 2019)

Secured Convertible Promissory Note from the Company to Iliad Research and Trading, L.P., dated March 26, 2019 (Filed With SEC on March 28, 2019)

Security Agreement between the Company and Iliad Research and Trading, L.P., dated March 26, 2019 (Filed With SEC on March 28, 2019)

Promissory Note Payable to Pioneer Pharma (Hong Kong) Company Limited, dated February 27, 2019 (Filed With SEC on March 1, 2019)

Security Agreement, dated February 27, 2019 (Filed With SEC on March 1, 2019)

Non-Employee Director Compensation Program, as amended (Filed With SEC on October 11, 2018)

Share Purchase Agreement, dated February 5, 2018 (Filed With SEC on February 6, 2018)

Employment Agreement with Mr. Justin Hall, dated December 19, 2017 (Filed With SEC on December 20, 2017)

Non-Employee Director Compensation Plan (effective January 1, 2018) (Filed With SEC on December 15, 2017)

Employment Agreement with Lewis Stuart, dated November 21, 2017 (Filed With SEC on November 28, 2017)

Amended and Restated Share Purchase Agreement, dated November 20, 2017 (Filed With SEC on November 21, 2017)

Share Purchase Agreement dated November 13, 2017 (Filed With SEC on November 14, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 6, 2017)

NOVABAY PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 23, 2017)

COMMON STOCK PURCHASE WARRANT NovaBay Pharmaceuticals, Inc. (Filed With SEC on March 23, 2017)

NON-EMPLOYEE DIRECTOR COMPENSATION PLAN Effective January 1, 2017 (Filed With SEC on March 23, 2017)

AMENDMENT TO SEPARATION AGREEMENT (Filed With SEC on December 19, 2016)

OFFICE LEASE THE TOWERS EMERYVILLE EMERYVILLE, CALIFORNIA KBSIII Towers at Emeryville, LLC, a Delaware limited liability company as Landlord, and NOVABAY PHARMACEUTICALS, INC., a... (Filed With SEC on August 26, 2016)

SUBLEASE by and between NOVABAY PHARMACEUTICALS, INC., a Delaware corporation, as Sublandlord, and ZYMERGEN, INC., a Delaware corporation, as Subtenant, at Suite 550, EmeryStation... (Filed With SEC on July 15, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 27, 2016)

NOVABAY PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on April 5, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 5, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 5, 2016)

MUTUAL & GENERAL RELEASE (Filed With SEC on March 1, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 17, 2016)

PROMISSORY NOTE (Filed With SEC on January 14, 2016)

PROMISSORY NOTE (Filed With SEC on January 6, 2016)

COLLATERAL AGENCY AND INTERCREDITOR AGREEMENT (Filed With SEC on January 6, 2016)

SECURITY AGREEMENT (Filed With SEC on January 6, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 5, 2016)

SEPARATION AGREEMENT (Filed With SEC on November 19, 2015)

12,300,000 Shares of Common Stock par value $0.01 Warrants to purchase 11,070,000 Shares of Common Stock NOVABAY PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on October 27, 2015)

COMMON STOCK PURCHASE WARRANT NovaBay Pharmaceuticals, Inc. (Filed With SEC on October 27, 2015)

NOVABAY PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 27, 2015)

NOVABAY PHARMACEUTICALS, INC. Warrant to Purchase Common Stock (Filed With SEC on August 13, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 13, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 13, 2015)

Stock PURCHASE AGREEMENT (Filed With SEC on August 13, 2015)

ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on March 26, 2015)

AGREEMENT (Filed With SEC on March 26, 2015)

NOVABAY PHARMACEUTICALS, INC. Warrant to Purchase Common Stock (Filed With SEC on March 9, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 9, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 9, 2015)

5,900,000 Shares of Common Stock par value $0.01 Warrants to Purchase 4,425,000 Shares of Common Stock NovaBay Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 6, 2012)

NOVABAY PHARMACEUTICALS, INC. Warrant to Purchase Common Stock (Filed With SEC on December 6, 2012)

NOVABAY PHARMACEUTICALS, INC. Warrant to Purchase Common Stock (Filed With SEC on November 1, 2012)

INTERNATIONAL DISTRIBUTION AGREEMENT (Filed With SEC on November 1, 2012)

NOVABAY PHARMACEUTICALS, INC. UNIT PURCHASE AGREEMENT September 13, 2012 NOVABAY PHARMACEUTICALS, INC. UNIT PURCHASE AGREEMENT (Filed With SEC on November 1, 2012)

NOVABAY PHARMACEUTICALS, INC. 2007 OMNIBUS INCENTIVE PLAN (as amended and restated on June 12, 2008) (Filed With SEC on August 9, 2012)

SEVENTH AMENDMENT (Filed With SEC on August 9, 2012)

Executive Officer Cash Bonus Structure (Filed With SEC on March 27, 2012)

CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 27, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 27, 2012)

TERMINATION OF COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 10, 2011)

4,650,675 Shares of Common Stock and Warrants to Purchase up to 3,488,005 Shares of Common Stock NOVABAY PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT June 29, 2011 (Filed With SEC on June 29, 2011)

NOVABAY PHARMACEUTICALS, INC. Warrant to Purchase Common Stock (Filed With SEC on June 29, 2011)

2010 Bonus (Filed With SEC on May 16, 2011)

CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 10, 2011)

INDEMNITY AGREEMENT (Filed With SEC on August 12, 2010)

NovaBay Pharmaceuticals, Inc. Employee Incentive Cash Compensation Plan (Filed With SEC on March 30, 2010)

NON-EMPLOYEE DIRECTOR COMPENSATION PLAN Effective January 1, 2010 (Filed With SEC on March 30, 2010)

CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 30, 2010)

Executive Officer Cash Compensation Arrangements (Filed With SEC on March 30, 2010)

EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on March 30, 2010)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2010)

Placement Agent Agreement, dated August 21, 2009, by and between NovaBay Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on August 21, 2009)

Form of Warrant (Filed With SEC on August 21, 2009)

Retirement and Consulting Agreement dated January 1, 2009 by and Between the Registrant and John (Jack) OReilly (Filed With SEC on March 31, 2009)

NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on August 14, 2008)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2008)

AMENDMENT NUMBER 1 (the Amendment) (Filed With SEC on March 14, 2008)

FIFTH AMENDMENT to LEASE BETWEEN EMERY STATION OFFICE II, LLC (LANDLORD) (Filed With SEC on March 14, 2008)

NOVABAY PHARMACEUTICALS, INC. Common Shares UNDERWRITING AGREEMENT (Filed With SEC on September 20, 2007)

NOVABAY PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on September 20, 2007)

NOVABAY PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 20, 2007)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on August 10, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on July 5, 2007)

1 LICENSE AGREEMENT (Filed With SEC on July 5, 2007)

NOVABAY PHARMACEUTICALS, INC. 2007 OMNIBUS INCENTIVE PLAN Table of Contents (Filed With SEC on May 29, 2007)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 29, 2007)

NOVABAY PHARMACEUTICALS, INC. DIRECTOR COMPENSATION PLAN (Filed With SEC on May 29, 2007)

MASTER SECURITY AGREEMENT dated as of April 23, 2007 (Agreement) (Filed With SEC on May 29, 2007)

NOVACAL PHARMACEUTICALS, INC. 2002 STOCK OPTION PLAN (Filed With SEC on March 30, 2007)

NOVACAL PHARMACEUTICALS, INC. 2005 STOCK OPTION PLAN (Filed With SEC on March 30, 2007)

STOCK OPTION GRANT (Filed With SEC on March 30, 2007)

OFFICE LEASE BETWEEN EMERY STATION ASSOCIATES II, LLC (LANDLORD) (Filed With SEC on March 30, 2007)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 30, 2007)

FINANCIAL ADVISORY AND INVESTOR RELATIONS CONSULTING (Filed With SEC on March 30, 2007)

Category

Industry

Companies

Contracts

NovaBay Pharmaceuticals, Inc. Contracts & Agreements